About HEPTA Medical
HEPTA Medical is a Healthcare company based in Paris (France) founded in 2018. Minimally invasive ablation catheters for pulmonary nodules are developed endoscopically. HEPTA Medical has raised $6.3 million across 1 funding round from investors including Bpifrance, M&L Group and Cléry. Its chief executive, as recorded, is Thomas Bancel. HEPTA Medical offers products and services including Microwave Ablation Platform. Its focus areas include Life Sciences, Oncology, Medical Devices and Therapies.
Company details
HEPTA Medical was founded in 2018 in Paris, France, within the medical technology sector focused on oncology. An endoscopically delivered ablation catheter is being developed by the company, utilizing temperature-based feedback and real-time dosing to target and ablate pulmonary nodules, which serve as precursors to lung cancer. Operations center on non-surgical interventions for early-stage cancer treatment, with activities based in Europe.
- Headquarters Paris, France
- SectorsHealthcare
- Email••••••••
- Website heptamed.com
- Social LinkedIn
- Total Equity Funding$6.3M (USD)
in 1 rounds
- Latest Funding Round$6.3M (USD), Series A
Sep 2024
- InvestorsBpifrance
& 2 more
Products & Services of HEPTA Medical
HEPTA Medical offers a comprehensive portfolio of products and services, including Microwave Ablation Platform.
Platform for real-time monitoring of tissue during ablation procedures.
Funding Insights of HEPTA Medical
HEPTA Medical has successfully raised a total of $6.3M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.3 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.3M
- Total Rounds 1
- Last Round Series A — $6.3M
- First Round $6.3M
(Sep 2024)
- Investors Count 3
All 1 funding rounds of HEPTA Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $6.3M | Series A | – | Bpifrance |
3 investors in total: 3 institutional.
Investors in HEPTA Medical
HEPTA Medical has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Bpifrance, M&L Group and Cléry.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A family investment firm based in Singapore, diversified across sectors. | mnlhealthcare.com | Singapore, Singapore | ||
Corporate consultancy, advisory, and funding services are provided to businesses. | 2012 | bpifrance.com | Maisons Alfort, France | |
Impact investments are managed by Cléry for sustainable returns. | clery-ig.fr | Paris, France |
Investor details for HEPTA Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of HEPTA Medical
1 people are tracked at HEPTA Medical (1 in leadership).
| Name | Role | Group |
|---|---|---|
Thomas Bancel | CEO | Leadership |
Complete people profiles for HEPTA Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of HEPTA Medical
2 dated milestones of HEPTA Medical across 6 years, from founding to its latest funding, stage changes and deals.
- Founded HEPTA Medical is founded.
- Funding First funding round of $6.3M.
Web traffic of HEPTA Medical
The website of HEPTA Medical (heptamed.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▲ 108.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about HEPTA Medical
HEPTA Medical was founded in 2018 and raised its 1st funding round 6 years after it was founded.
HEPTA Medical is headquartered in Paris, France.
Thomas Bancel is the CEO of HEPTA Medical, as recorded in our data.
HEPTA Medical is a funded company, having raised a total of $6.3M across 1 funding round to date. The company's 1st funding round was a Series A of $6.3M, raised on Sep 2024.
HEPTA Medical was founded in 2018 in Paris, France, within the medical technology sector focused on oncology. An endoscopically delivered ablation catheter is being developed by the company, utilizing temperature-based feedback and real-time dosing to target and ablate pulmonary nodules, which serve as precursors to lung cancer. Operations center on non-surgical interventions for early-stage cancer treatment, with activities based in Europe.
HEPTA Medical offers Microwave Ablation Platform.